title: Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group.
abstract: The Biostatistics and Methodological Innovation Working (BMIW) Group is one of several working groups within the CANadian Network and Centre for Trials INternationally (CANNeCTIN). This programme received funding from the Canadian Institutes of Health Research and the Canada Foundation for Innovation beginning in 2008, to enhance the infrastructure and build capacity for large Canadian-led clinical trials in cardiovascular diseases (CVD) and diabetes mellitus (DM). The overall aims of the BMIW Group's programme within CANNeCTIN, are to advance biostatistical and methodological research, and to build biostatistical capacity in CVD and DM. Our program of research and training includes: monthly videoconferences on topical biostatistical and methodological issues in CVD/DM clinical studies; providing presentations on methods issues at the annual CANNeCTIN meetings; collaborating with clinician investigators on their studies; training young statisticians in biostatistics and methods in CVD/DM trials and organizing annual symposiums on topical methodological issues. We are focused on the development of new biostatistical methods and the recruitment and training of highly qualified personnel--who will become leaders in the design and analysis of CVD/DM trials. The ultimate goal is to enhance global health by contributing to efforts to reduce the burden of CVD and DM.
authors.affiliation: Department of Clinical Epidemiology and Biostatistics, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada. thabanl@mcmaster.ca
authors.forename: Lehana
authors.initials: L
authors.lastname: Thabane
authors.forename: George
authors.initials: G
authors.lastname: Wells
authors.forename: Richard
authors.initials: R
authors.lastname: Cook
authors.forename: Robert
authors.initials: R
authors.lastname: Platt
authors.forename: Janice
authors.initials: J
authors.lastname: Pogue
authors.forename: Eleanor
authors.initials: E
authors.lastname: Pullenayegum
authors.forename: David
authors.initials: D
authors.lastname: Matthews
authors.forename: Tara
authors.initials: T
authors.lastname: McCready
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Devereaux
authors.forename: John A
authors.initials: JA
authors.lastname: Cairns
authors.forename: Salim
authors.initials: S
authors.lastname: Yusuf
mesh_terms: D035843:Biomedical Research / Q000458:organization & administration / Q000706:statistics & numerical data*; D056808:Biostatistics; D002170:Canada; D057191:Capacity Building; D002318:Cardiovascular Diseases / Q000628:therapy*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D003226:Congresses as Topic; D003627:Data Interpretation, Statistical; D003920:Diabetes Mellitus / Q000628:therapy*; D006302:Health Services Research / Q000458:organization & administration / Q000706:statistics & numerical data*; D006801:Humans; D033181:Information Dissemination; D008611:Mentors; D009937:Organizational Objectives; D016730:Program Development; D016896:Treatment Outcome; D049269:Videoconferencing